Dx Deals: New Premerger Regulations Could Slow Down Pace of Transactions
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Most of Invitae's employees will be hired by Labcorp, which expects the deal to add about $275 million in annual revenue